As of 2025-09-19, the Relative Valuation of Cue Biopharma Inc (CUE) is (7.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.72 USD, the upside of Cue Biopharma Inc based on Relative Valuation is -1070.5%.
The range of the Relative Valuation is (5.63) - (7.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 15.6x | 13.9x |
| Forward P/E multiples | 11.0x - 17.0x | 13.8x |
| Fair Price | (5.63) - (7.89) | (7.01) |
| Upside | -879.2% - -1191.7% | -1070.5% |
| Date | P/E |
| 2025-09-17 | -1.43 |
| 2025-09-16 | -1.47 |
| 2025-09-15 | -1.46 |
| 2025-09-12 | -1.47 |
| 2025-09-11 | -1.51 |
| 2025-09-10 | -1.51 |
| 2025-09-09 | -1.52 |
| 2025-09-08 | -1.54 |
| 2025-09-05 | -1.54 |
| 2025-09-04 | -1.55 |
| 2025-09-03 | -1.57 |
| 2025-09-02 | -1.57 |
| 2025-08-29 | -1.54 |
| 2025-08-28 | -1.58 |
| 2025-08-27 | -1.63 |
| 2025-08-26 | -1.66 |
| 2025-08-25 | -1.62 |
| 2025-08-22 | -1.63 |
| 2025-08-21 | -1.60 |
| 2025-08-20 | -1.60 |
| 2025-08-19 | -1.61 |
| 2025-08-18 | -1.62 |
| 2025-08-15 | -1.63 |
| 2025-08-14 | -1.56 |
| 2025-08-13 | -1.60 |
| 2025-08-12 | -1.56 |
| 2025-08-11 | -1.64 |
| 2025-08-08 | -1.64 |
| 2025-08-07 | -1.60 |
| 2025-08-06 | -1.55 |
| 2025-08-05 | -1.66 |
| 2025-08-04 | -1.51 |
| 2025-08-01 | -1.46 |
| 2025-07-31 | -1.48 |
| 2025-07-30 | -1.61 |
| 2025-07-29 | -1.62 |
| 2025-07-28 | -1.62 |
| 2025-07-25 | -1.74 |
| 2025-07-24 | -1.79 |
| 2025-07-23 | -1.76 |
| 2025-07-22 | -1.78 |
| 2025-07-21 | -1.74 |
| 2025-07-18 | -1.78 |
| 2025-07-17 | -1.66 |
| 2025-07-16 | -1.69 |
| 2025-07-15 | -1.38 |
| 2025-07-14 | -1.54 |
| 2025-07-11 | -1.51 |
| 2025-07-10 | -1.57 |
| 2025-07-09 | -1.55 |